Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States

被引:668
|
作者
Xu, Fujie
Sternberg, Maya R.
Kottiri, Benny J.
McQuillan, Geraldine M.
Lee, Francis K.
Nahmias, Andre J.
Berman, Stuart M.
Markowitz, Lauri E.
机构
[1] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA
[2] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA
来源
关键词
D O I
10.1001/jama.296.8.964
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context Herpes simplex virus type 1 (HSV-1) and type 2 are common infections worldwide. Herpes simplex virus type 2 (HSV-2) is the cause of most genital herpes and is almost always sexually transmitted. In contrast, HSV-1 is usually transmitted during childhood via nonsexual contacts. Preexisting HSV-1 antibodies can alleviate clinical manifestations of subsequently acquired HSV-2. Furthermore, HSV-1 has become an important cause of genital herpes in some developed countries. Objective To examine trends in HSV-1 and HSV-2 seroprevalence in the United States in 1999-2004 compared with 1988-1994. Design, Settings, and Participants Cross-sectional, nationally representative surveys (US National Health and Nutrition Examination Surveys [ NHANES]), were used to compare national seroprevalence estimates from 1999-2004 with those from 19881994, and changes in HSV-1 and HSV-2 seroprevalence since 1976-1980 were reviewed. Persons aged 14 to 49 years were included in these analyses. Main Outcome Measures Seroprevalence of HSV-1 and HSV-2 antibodies based on results from type-specific immunodot assays; diagnosis of genital herpes. Results The overall age-adjusted HSV-2 seroprevalence was 17.0% (95% confidence interval [CI], 15.8%-18.3%) in 1999-2004 and 21.0% (95% CI, 19.1%-23.1%) in 1988-1994, a relative decrease of 19.0% between the 2 surveys (95% CI, -28.6% to -9.5%; P < .001). Decreases in HSV-2 seroprevalence were especially concentrated in persons aged 14 to 19 years between 1988 and 2004. In adolescents aged 17 to 19 years and young adults, the decreases in HSV-2 seroprevalence were significant even after adjusting for changes in sexual behaviors. Among those infected with HSV-2, the percentage who reported having been diagnosed with genital herpes was statistically different (14.3% in 1999-2004 and 9.9% in 1988-1994; P =.02). Seroprevalence of HSV-1 decreased from 62.0% (95% CI, 59.6%-64.6%) in 1988-1994 to 57.7% (95% CI, 55.9%-59.5%) in 1999-2004, a relative decrease of 6.9% between the 2 surveys (95% CI, -11.6% to -2.3%; P =. 006). Among persons infected with HSV-1 but not with HSV-2, a higher percentage reported having been diagnosed with genital herpes in 1999-2004 compared with 1988-1994 (1.8% vs 0.4%, respectively; P < .001). Conclusions These data show declines in HSV-2 seroprevalence, suggesting that the trajectory of increasing HSV-2 seroprevalence in the United States has been reversed. Seroprevalence of HSV-1 decreased but the incidence of genital herpes caused by HSV-1 may be increasing.
引用
收藏
页码:964 / 973
页数:10
相关论文
共 50 条
  • [1] Seroprevalence of herpes simplex virus type 1 and type 2 in pregnant women in the United States
    Xu, Fujie
    Markowitz, Lauri E.
    Gottlieb, Sami L.
    Berman, Stuart M.
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2007, 196 (01) : 43 - 45
  • [2] Seroprevalence of herpes simplex virus type 1 in children in the united states
    Xu, Fujie
    Lee, Francis K.
    Morrow, Rhoda A.
    Sternberg, Maya R.
    Luther, Kristina E.
    Dubin, Gary
    Markowitz, Lauri E.
    [J]. JOURNAL OF PEDIATRICS, 2007, 151 (04): : 374 - 377
  • [3] National seroprevalence and trends in herpes simplex virus type 1 in the United States, 1976-1994
    Schillinger, JA
    Xu, FJ
    Sternberg, MR
    Armstrong, GL
    Lee, FK
    Nahmias, AJ
    Mcquillan, GM
    St Louis, ME
    Markowitz, LE
    [J]. SEXUALLY TRANSMITTED DISEASES, 2004, 31 (12) : 753 - 760
  • [4] Characterizing herpes simplex virus type 1 and type 2 seroprevalence declines and epidemiological association in the United States
    Chemaitelly, Hiam
    Nagelkerke, Nico
    Omori, Ryosuke
    Abu-Raddad, Laith J.
    [J]. PLOS ONE, 2019, 14 (06):
  • [5] Seroprevalence and coinfection with herpes simplex virus type 1 and type 2 in the United States, 1988-1994
    Xu, FJ
    Schillinger, JA
    Sternberg, MR
    Johnson, RE
    Lee, FK
    Nahmias, AJ
    Markowitz, LE
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2002, 185 (08): : 1019 - 1024
  • [6] Seroprevalence of herpes simplex virus type 1 and type 2 in Turkey
    Dolar, N.
    Serdaroglu, S.
    Yilmaz, G.
    Ergin, S.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2006, 20 (10) : 1232 - 1236
  • [7] Seroprevalence of herpes simplex virus type 1 and type 2 among reproductive aged women in the United States, 1988-1994.
    Xu, FJ
    Sternberg, M
    Schillinger, J
    Markowitz, L
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2000, 151 (11) : S14 - S14
  • [8] Seroprevalence and seroincidence of herpes simplex virus type 1 and herpes simplex virus type 2 infections in a cohort of adolescents in Italy
    Suligoi, B
    Torri, A
    Grilli, G
    Tanzi, E
    Palú, G
    [J]. SEXUALLY TRANSMITTED DISEASES, 2004, 31 (10) : 608 - 610
  • [9] Incidence of herpes simplex virus type 2 infection in the United States
    Armstrong, GL
    Schillinger, J
    Markowitz, L
    Nahmias, AJ
    Johnson, RE
    McQuillan, GM
    St Louis, ME
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2001, 153 (09) : 912 - 920
  • [10] Herpes simplex virus type 2 in the United States, 1976 TO 1994
    Fleming, DT
    McQuillan, GM
    Johnson, RE
    Nahmias, AJ
    Aral, SO
    Lee, FK
    StLouis, ME
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (16): : 1105 - 1111